OMDA · Omada Health, Inc.
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| $334M – $340M | $309.76M | $260.21MG | $169.8M | $122.78M | |
| — | $98.55M | $89.27M | $66.92M | $52.81M | |
| — | $211.21M | $170.94M | $102.88M | $69.97M | |
| — | — | 65.69% | 60.59% | 56.99% | |
| — | $49.18M | $40.68M | $35.92M | $33.74M | |
| — | $104.23M | $90.04M | $68.05M | $66.25M | |
| — | $58.27M | $52.18M | $42.56M | $35.98M | |
| — | — | $1.9M | $2M | $2M | |
| — | $5.9M | $5.49M | $4.8M | $4.45M | |
| — | $211.68M | $182.91M | $146.53M | $135.97M | |
| — | -$464K | -$11.97M | -$43.65M | -$66M | |
| — | — | -4.6% | -25.71% | -53.75% | |
| — | $5.43M | -$6.48M | -$38.85M | -$61.55M | |
| — | $398K | $2.53M | $4.51M | $4.71M | |
| — | $7.49M | $5.31M | $805K | $5.78M | |
| — | $4.77M | -$806K | -$3.48M | -$1.51M | |
| — | $4.31M | -$12.78M | -$47.14M | -$67.51M | |
| — | $0 | $0 | $0 | $0 | |
| — | $4.31M | -$12.78M | -$47.14M | -$67.51M | |
| — | — | -4.91% | -27.76% | -54.98% | |
| — | $4.31M | -$12.78M | -$47.14M | -$67.51M | |
| USD/shares | — | $1.08 | -$0.35 | -$6.11 | -$9.52 |
| USD/shares | — | $1.07 | -$0.35 | -$6.11 | -$9.52 |
| shares | — | — | 36.64M | 7.72M | 7.09M |
| shares | — | — | 36.64M | 7.72M | 7.09M |
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 25 similar-size Health Information Services companies (of 45 listed).
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.
Valuation over time computed as of each quarter's filing date
EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Reportable Segment | $260,210,000 | $169,800,000 | $122,784,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Service | $241,043,000 | $157,789,000 | $114,531,000 |
| Hardware | $19,167,000 | $12,011,000 | $8,253,000 |